nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.141	0.167	CbGbCtD
Flupentixol—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.127	0.151	CbGbCtD
Flupentixol—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.11	0.131	CbGbCtD
Flupentixol—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.107	0.127	CbGbCtD
Flupentixol—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0964	0.115	CbGbCtD
Flupentixol—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0964	0.115	CbGbCtD
Flupentixol—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0925	0.11	CbGbCtD
Flupentixol—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0715	0.085	CbGbCtD
Flupentixol—DDC—nerve—acquired immunodeficiency syndrome	0.0157	0.124	CbGeAlD
Flupentixol—DDC—blood plasma—acquired immunodeficiency syndrome	0.0119	0.0936	CbGeAlD
Flupentixol—DRD1—nerve—acquired immunodeficiency syndrome	0.0116	0.0909	CbGeAlD
Flupentixol—DRD2—nerve—acquired immunodeficiency syndrome	0.00683	0.0537	CbGeAlD
Flupentixol—HTR2A—nerve—acquired immunodeficiency syndrome	0.0045	0.0354	CbGeAlD
Flupentixol—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00383	0.0302	CbGeAlD
Flupentixol—DDC—lung—acquired immunodeficiency syndrome	0.00382	0.0301	CbGeAlD
Flupentixol—DDC—nervous system—acquired immunodeficiency syndrome	0.00354	0.0278	CbGeAlD
Flupentixol—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.0034	0.0268	CbGeAlD
Flupentixol—DDC—central nervous system—acquired immunodeficiency syndrome	0.0034	0.0268	CbGeAlD
Flupentixol—DRD2—retina—acquired immunodeficiency syndrome	0.00283	0.0223	CbGeAlD
Flupentixol—DDC—brain—acquired immunodeficiency syndrome	0.0027	0.0213	CbGeAlD
Flupentixol—DDC—lymph node—acquired immunodeficiency syndrome	0.00261	0.0206	CbGeAlD
Flupentixol—DRD1—nervous system—acquired immunodeficiency syndrome	0.0026	0.0205	CbGeAlD
Flupentixol—DRD1—central nervous system—acquired immunodeficiency syndrome	0.0025	0.0197	CbGeAlD
Flupentixol—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00223	0.0176	CbGeAlD
Flupentixol—CHRM1—lung—acquired immunodeficiency syndrome	0.00206	0.0162	CbGeAlD
Flupentixol—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00205	0.0161	CbGeAlD
Flupentixol—DRD1—brain—acquired immunodeficiency syndrome	0.00199	0.0156	CbGeAlD
Flupentixol—ADRA1A—blood—acquired immunodeficiency syndrome	0.00193	0.0152	CbGeAlD
Flupentixol—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00191	0.015	CbGeAlD
Flupentixol—HTR2A—retina—acquired immunodeficiency syndrome	0.00186	0.0147	CbGeAlD
Flupentixol—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00184	0.0144	CbGeAlD
Flupentixol—DRD2—lung—acquired immunodeficiency syndrome	0.00166	0.013	CbGeAlD
Flupentixol—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00157	0.0123	CbGeAlD
Flupentixol—DRD2—nervous system—acquired immunodeficiency syndrome	0.00154	0.0121	CbGeAlD
Flupentixol—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00151	0.0119	CbGeAlD
Flupentixol—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00148	0.0116	CbGeAlD
Flupentixol—CHRM1—brain—acquired immunodeficiency syndrome	0.00146	0.0115	CbGeAlD
Flupentixol—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00131	0.0103	CbGeAlD
Flupentixol—HTR2A—blood—acquired immunodeficiency syndrome	0.00125	0.00982	CbGeAlD
Flupentixol—ABCB1—retina—acquired immunodeficiency syndrome	0.00122	0.00962	CbGeAlD
Flupentixol—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.0012	0.00946	CbGeAlD
Flupentixol—ADRA1A—brain—acquired immunodeficiency syndrome	0.0012	0.00942	CbGeAlD
Flupentixol—DRD2—brain—acquired immunodeficiency syndrome	0.00117	0.00924	CbGeAlD
Flupentixol—HTR2A—vagina—acquired immunodeficiency syndrome	0.00116	0.0091	CbGeAlD
Flupentixol—HTR2A—lung—acquired immunodeficiency syndrome	0.00109	0.00861	CbGeAlD
Flupentixol—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00101	0.00797	CbGeAlD
Flupentixol—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000975	0.00767	CbGeAlD
Flupentixol—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000868	0.00684	CbGeAlD
Flupentixol—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000858	0.00675	CbGeAlD
Flupentixol—ABCB1—blood—acquired immunodeficiency syndrome	0.000817	0.00643	CbGeAlD
Flupentixol—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000791	0.00623	CbGeAlD
Flupentixol—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000787	0.0062	CbGeAlD
Flupentixol—HTR2A—brain—acquired immunodeficiency syndrome	0.000774	0.00609	CbGeAlD
Flupentixol—ABCB1—vagina—acquired immunodeficiency syndrome	0.000758	0.00596	CbGeAlD
Flupentixol—ABCB1—lung—acquired immunodeficiency syndrome	0.000716	0.00564	CbGeAlD
Flupentixol—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000663	0.00522	CbGeAlD
Flupentixol—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000639	0.00503	CbGeAlD
Flupentixol—ABCB1—brain—acquired immunodeficiency syndrome	0.000507	0.00399	CbGeAlD
Flupentixol—ABCB1—lymph node—acquired immunodeficiency syndrome	0.00049	0.00386	CbGeAlD
Flupentixol—DRD2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000141	0.00445	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000139	0.00439	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000138	0.00434	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000137	0.00432	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000136	0.0043	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000136	0.00427	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000135	0.00425	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000134	0.00423	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000133	0.0042	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000133	0.00418	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000132	0.00416	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000131	0.00413	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00013	0.00409	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000129	0.00407	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000129	0.00406	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000128	0.00404	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000127	0.00401	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00398	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00012	0.00379	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000119	0.00376	CbGpPWpGaD
Flupentixol—DRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000119	0.00375	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000117	0.0037	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000117	0.00368	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000116	0.00365	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000115	0.00362	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00357	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00357	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000113	0.00356	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000112	0.00354	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000112	0.00354	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000111	0.00348	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00011	0.00348	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00011	0.00348	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00011	0.00346	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00011	0.00346	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000108	0.00341	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00341	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000108	0.0034	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000107	0.00338	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000102	0.00321	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000101	0.00317	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0001	0.00315	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.89e-05	0.00312	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.84e-05	0.0031	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.69e-05	0.00305	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.68e-05	0.00305	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.45e-05	0.00298	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	9.31e-05	0.00294	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.09e-05	0.00286	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.98e-05	0.00283	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.95e-05	0.00282	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.9e-05	0.0028	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.84e-05	0.00278	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.79e-05	0.00277	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.76e-05	0.00276	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.65e-05	0.00273	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.61e-05	0.00271	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.55e-05	0.00269	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.55e-05	0.00269	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.54e-05	0.00269	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.41e-05	0.00265	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.41e-05	0.00265	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.4e-05	0.00265	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.37e-05	0.00264	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.37e-05	0.00264	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.36e-05	0.00263	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.35e-05	0.00263	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	8.28e-05	0.00261	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.24e-05	0.00259	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.24e-05	0.00259	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.23e-05	0.00259	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.22e-05	0.00259	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.17e-05	0.00258	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.14e-05	0.00257	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.05e-05	0.00253	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.01e-05	0.00252	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.97e-05	0.00251	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.84e-05	0.00247	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.76e-05	0.00244	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.69e-05	0.00242	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.57e-05	0.00239	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.55e-05	0.00238	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.53e-05	0.00237	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.43e-05	0.00234	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.41e-05	0.00234	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.39e-05	0.00233	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.28e-05	0.00229	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.83e-05	0.00215	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.8e-05	0.00214	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.53e-05	0.00206	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.53e-05	0.00206	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.5e-05	0.00205	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.4e-05	0.00202	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.4e-05	0.00202	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.4e-05	0.00202	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.36e-05	0.00201	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.26e-05	0.00197	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.18e-05	0.00195	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	6.03e-05	0.0019	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.91e-05	0.00186	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.86e-05	0.00185	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.81e-05	0.00183	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.81e-05	0.00183	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.76e-05	0.00182	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.73e-05	0.00181	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.64e-05	0.00178	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	5.56e-05	0.00175	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	5.37e-05	0.00169	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.16e-05	0.00163	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.14e-05	0.00162	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.08e-05	0.0016	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.06e-05	0.00159	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.05e-05	0.00159	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.03e-05	0.00158	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.97e-05	0.00157	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.95e-05	0.00156	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.93e-05	0.00155	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.93e-05	0.00155	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.93e-05	0.00155	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.87e-05	0.00153	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.85e-05	0.00153	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.85e-05	0.00153	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.83e-05	0.00152	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.83e-05	0.00152	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.83e-05	0.00152	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.83e-05	0.00152	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.79e-05	0.00151	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.75e-05	0.0015	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.75e-05	0.0015	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.75e-05	0.0015	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.75e-05	0.0015	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.73e-05	0.00149	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.73e-05	0.00149	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.67e-05	0.00147	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.65e-05	0.00147	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.65e-05	0.00147	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.59e-05	0.00145	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.57e-05	0.00144	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.57e-05	0.00144	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.49e-05	0.00142	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	4.49e-05	0.00141	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.46e-05	0.00141	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.42e-05	0.00139	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.39e-05	0.00138	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.39e-05	0.00138	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.39e-05	0.00138	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.38e-05	0.00138	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.37e-05	0.00138	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.35e-05	0.00137	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.32e-05	0.00136	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.32e-05	0.00136	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.3e-05	0.00135	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.29e-05	0.00135	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.29e-05	0.00135	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.23e-05	0.00133	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.23e-05	0.00133	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.04e-05	0.00127	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.98e-05	0.00125	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ALB—acquired immunodeficiency syndrome	3.84e-05	0.00121	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.72e-05	0.00117	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.67e-05	0.00116	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.65e-05	0.00115	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.64e-05	0.00115	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.62e-05	0.00114	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.62e-05	0.00114	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.6e-05	0.00113	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.56e-05	0.00112	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.54e-05	0.00112	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.54e-05	0.00112	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.49e-05	0.0011	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.47e-05	0.00109	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.45e-05	0.00109	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.43e-05	0.00108	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.43e-05	0.00108	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.4e-05	0.00107	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.34e-05	0.00105	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.31e-05	0.00104	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.29e-05	0.00104	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.28e-05	0.00103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.27e-05	0.00103	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.26e-05	0.00103	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.24e-05	0.00102	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.23e-05	0.00102	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.22e-05	0.00101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.22e-05	0.00101	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.19e-05	0.00101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.17e-05	0.000998	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.05e-05	0.00096	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.01e-05	0.000947	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3e-05	0.000945	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.98e-05	0.00094	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.98e-05	0.000937	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.96e-05	0.000932	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.94e-05	0.000927	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.94e-05	0.000925	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.9e-05	0.000913	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.76e-05	0.000868	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.71e-05	0.000854	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.7e-05	0.00085	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.66e-05	0.000837	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.61e-05	0.000823	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.59e-05	0.000816	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.59e-05	0.000816	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.57e-05	0.00081	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.55e-05	0.000803	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.55e-05	0.000803	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.54e-05	0.000799	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.54e-05	0.000799	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.53e-05	0.000798	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.5e-05	0.000787	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.5e-05	0.000787	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.000741	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000725	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2e-05	0.00063	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000621	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.94e-05	0.000612	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.000611	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.000608	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.91e-05	0.000603	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000602	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.000599	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.9e-05	0.000598	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.88e-05	0.000593	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.87e-05	0.00059	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.000589	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.84e-05	0.000581	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.00056	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.000551	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.000548	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000547	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000539	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.71e-05	0.000539	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.7e-05	0.000536	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000527	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000428	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.35e-05	0.000426	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000323	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000322	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000318	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1e-05	0.000317	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1e-05	0.000316	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.99e-06	0.000315	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.89e-06	0.000312	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.84e-06	0.00031	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	9.37e-06	0.000295	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.99e-06	0.000252	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.03e-06	0.00019	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.93e-06	0.000187	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.9e-06	0.000186	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.81e-06	0.000183	CbGpPWpGaD
